|

Drug: 5 mg BGM0504 Administered SC Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • BrightGene Bio-Medical Technology Co., Ltd.2

Indications

  • Type 2 Diabetes Mellitus (T2DM)2
  • Diabetes2

Other2 trials

A Study of BGM0504 in Participants with Type 2 Diabetes
Phase 3
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.